Lazard Upgrades Sequenom (SQNM) to Buy, Sets $13 Price Target

March 23, 2010 7:10 AM EDT Send to a Friend
Lazard Capital Markets upgrades Sequenom (Nasdaq: SQNM) from Hold to Buy. The firm also set a $13 price target.
This article: 94 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login